Cyclin D1 in breast cancer pathogenesis

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Cyclin D1 is a well-established oncogene implicated in various human cancers, notably breast cancer.
• Its precise role in driving neoplasia at the cellular level remains incompletely understood.
• Growing evidence suggests non-cell cycle regulatory pathways may be involved in cyclin D1's oncogenic function.

Purpose of the Study:

• To review and synthesize current evidence on the pathogenetic mechanisms of cyclin D1 in human cancer.
• To evaluate the implications of emerging mechanistic insights for therapeutic strategies targeting cyclin D1.

Main Methods:

• Literature review of available evidence emphasizing human disease relevance.
• Analysis of studies investigating cyclin D1's role in cancer development.
• Synthesis of findings related to cyclin D1's cellular functions and oncogenic pathways.

Main Results:

• Cyclin D1 is confirmed as a significant oncogene in breast cancer and other tumors.
• Evidence points to cyclin D1 potentially operating through pathways independent of its canonical cell cycle regulatory function.
• The exact cellular mechanisms driving neoplasia via aberrant cyclin D1 expression require further elucidation.

Conclusions:

• Targeting cyclin D1 for cancer therapy holds promise, particularly in breast cancer.
• Therapeutic approaches directly targeting the cyclin D1 gene or its products may be more successful.
• Future strategies should consider the evolving understanding of cyclin D1's diverse oncogenic mechanisms, potentially beyond cell cycle regulation.